VR meets ketamine: a new hope for stubborn depression?
NCT ID NCT06781697
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This small pilot study tests whether adding virtual reality (VR) to standard ketamine infusions can better ease symptoms of treatment-resistant depression. All 31 participants will receive ketamine, and half will also wear a VR headset during treatment. The main goal is to see if a larger trial is possible, but researchers will also compare mood changes between the two groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M4N 3M5, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain 'Radio' tunes into Depression's neural signals
- Magic mushroom compound tested for dual relief of chronic pain and depression
- Ketamine plus talk therapy shows promise for stubborn depression
- Brain zaps guided by scans: a new hope for untreatable depression?
- Magic mushroom compound may offer new hope for stubborn depression
- Can a blood test predict who will respond to ketamine for depression?